A Cancer Cell’s Weight Predicts Its Therapeutic Opponent

Scientists in the U.S. have shown how measuring changes in the weight of individual living cancer cells taken from multiple myeloma (MM) patients can accurately predict whether their cancer will respond to different drug treatments. The microfluidic device, known as a suspended microchannel resonator (SMR), is capable of weighing cells 10 to 100 times more accurately than any other existing method, making it possible to measure changes in the growth, or mass accumulation rate (MAR), of single ce